FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

764485007: Cutaneous patch (qualifier value)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3650009010 Conventional release cutaneous patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3650010017 Conventional release cutaneous patch en Synonym Active Entire term case insensitive SNOMED CT core module
3650011018 Cutaneous patch en Synonym Active Entire term case insensitive SNOMED CT core module
1116641000001117 Cutaneous patch (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous patch Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Cutaneous patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Cutaneous patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Cutaneous patch Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Cutaneous patch Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Cutaneous patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely camphor 12 microgram/1 milligram and menthol 57 microgram/1 milligram and methyl salicylate 63 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Product containing precisely menthol 30 microgram/1 milligram and methyl salicylate 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form False Cutaneous patch Inferred relationship Existential restriction modifier
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) Has manufactured dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Capsaicin 179mg cutaneous patches Has manufactured dose form False Cutaneous patch Inferred relationship Existential restriction modifier
Capsaicin 179mg cutaneous patches 1 patch Has dispensed dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) 1 patch Has dispensed dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Capsaicin 179mg cutaneous patches Has dispensed dose form True Cutaneous patch Inferred relationship Existential restriction modifier
Qutenza 179mg cutaneous patches (Astellas Pharma Ltd) Has dispensed dose form True Cutaneous patch Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start